James Wang, Country Managing Partner of Ernst & Young Taiwan explains why Taiwan’s DIG (Diversify-Innovative-Globalize) strategy is crucial for…

Wayne Samuels, partner at PwC Canada, discusses the most pressing issues in the country’s healthcare system and pharmaceutical industry, and…

The CEO of OBIO discusses Ontario’s challenges and opportunities in life sciences, highlighting some of the key initiatives that the organization is…

Warren Shapiro, manager of the North American division of Brunel’s life science sector, offers his insights into Canada’s immense human resources…

Mario Piccinin and Lara Iob of EY Canada discuss some of the key trends of the country’s biotech industry and the affiliate’s dedication to…

The president of Biotalent Canada discusses the advantages of being wholly aligned with the government, why the BioTalent is a necessary link between…

The president & CEO of CQDM discusses her vision of how CQDM’s activities can have a direct impact on the development of safer and more…

President & Chair of Life Sciences discusses why Canada is not a global competitor in the Life Sciences industry and what needs to change…

Mr. Pierre Laurin is a senior executive with 28 years of experience in the pharmaceutical and biotechnology industry. Involved in the development of…

Business & Decision Life Science was founded back in 2007, although that department existed within the group’s structure long before that.…

Rogerio, you were one of the people responsible for integrating two well-established companies in the Brazilian market with the acquisition of Exel by…

In 2010, South Africa officially joined the BRICS grouping. The Indian and Russian work environments are familiar to you, considering your significant…